Danaher Corp
DHRNYSEIndustrial Instruments For Measurement, Display, and ControlFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 26, 2026Last filing: 10-Q on Jul 21, 2026Score 12/3025% above fair value
$232.23−4.75 (-2.00%)
Close on Oct 30, 2026Market cap $163.25BP/E 41.2Yield –
Danaher Diagnostics — Biên Adjusted EBITDA by Year
Diagnostics — Biên Adjusted EBITDA (%)
Danaher Diagnostics — Biên Adjusted EBITDA: 32.7% in FY2025, down 1.1 pts from a year earlier.
Latest, FY2025
32.7%
Period ended Dec 31, 2025
Change on a year earlier
-1.1 pts
33.8% in FY2024
History
5 years
Since FY2021
Sources
3
Documents cited below
Where the FY2025 figure comes from
Source: Danaher IR — nongaap_2025Q4 ↗
Reported in Danaher Non-GAAP Reconciliations & Supplemental Data (8-K / IR PDF).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Diagnostics — Biên Adjusted EBITDA (%) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 32.7% | -1.1 pts | Danaher IR — nongaap_2025Q4 ↗ |
| FY2024 | Dec 31, 2024 | 33.8% | +2.4 pts | Danaher IR — nongaap_2025Q4 ↗ |
| FY2023 | Dec 31, 2023 | 31.4% | -5.7 pts | Danaher IR — nongaap_2024Q4 ↗ |
| FY2022 | Dec 31, 2022 | 37.1% | +1.7 pts | Danaher IR — nongaap_ex_veralto ↗ |
| FY2021 | Dec 31, 2021 | 35.4% | – | Danaher IR — nongaap_ex_veralto ↗ |
Cite this data
StockData. (2026). Danaher Diagnostics — Biên Adjusted EBITDA (%), annual FY2021–FY2025 [Data set]. Compiled from Danaher SEC filings and investor materials. https://stockdatahq.com/stocks/dhr/kpis/adj-ebitda-margin-diag
See every metric in the Danaher KPI table. Data updated Nov 2, 2026.